A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma

S.R. Pasricha, Andrew Grigg, J. Catalano, Michael Leahy, C. Underhill, C. Arthur, J. D'Rozario, R. Lowenthal, K. Reed, A. Spencer

    Research output: Contribution to journalArticle

    14 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)3192-3198
    JournalCancer
    Volume113
    Issue number11
    DOIs
    Publication statusPublished - 2008

    Cite this

    Pasricha, S. R., Grigg, A., Catalano, J., Leahy, M., Underhill, C., Arthur, C., ... Spencer, A. (2008). A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma. Cancer, 113(11), 3192-3198. https://doi.org/10.1002/cncr.23915